Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 3/2016

07.09.2016 | Schwerpunkt

Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical

verfasst von: Dipl.-Ing. Jan Zdarek, Carsten W. Israel

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Modern implantable cardioverter/defibrillator (ICD) systems offer a multitude of algorithms to optimize performance in sensing and tachycardia detection even in difficult circumstances (e. g., ventricular tachycardia during supraventricular tachycardia, fine ventricular fibrillation with intermittent undersensing), to reliably discriminate sustained ventricular tachyarrhythmia from noise, nonsustained and supraventricular tachyarrhythmia, and to limit shock therapy only to those arrhythmias that definitely need to be treated by a shock. A disadvantage of these multiple algorithms is the complexity of annotated tracings that makes it sometimes difficult to understand why the ICD did what it did. If a tachycardia classification was wrong, it may be thus difficult to find the best way to reprogram the device to avoid another misclassification. This review explains in detail the algorithms used for tachycardia detection, discrimination, and prevention of inappropriate therapy in single- and dual-chamber ICDs manufactured by St. Jude Medical. Knowledge of these features may help to optimize ICD treatment in patients fitted with these devices.
Literatur
1.
Zurück zum Zitat Bailin SJ, Niebauer M, Tomassoni G et al (2003) Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol 14:144–149CrossRefPubMed Bailin SJ, Niebauer M, Tomassoni G et al (2003) Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol 14:144–149CrossRefPubMed
4.
Zurück zum Zitat Dickstein K, Vardas PE, Auricchio A et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12:1526–1536. doi:10.1093/europace/euq392 CrossRefPubMed Dickstein K, Vardas PE, Auricchio A et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12:1526–1536. doi:10.​1093/​europace/​euq392 CrossRefPubMed
6.
Zurück zum Zitat Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017CrossRefPubMedPubMedCentral Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Powell BD, Saxon LA, Boehmer JP et al (2013) Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol 62:1674–1679. doi:10.1016/j.jacc.2013.04.083 CrossRefPubMed Powell BD, Saxon LA, Boehmer JP et al (2013) Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol 62:1674–1679. doi:10.​1016/​j.​jacc.​2013.​04.​083 CrossRefPubMed
9.
Zurück zum Zitat Schron EB, Exner DV, Yao Q et al (2002) Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105:589–594CrossRefPubMed Schron EB, Exner DV, Yao Q et al (2002) Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105:589–594CrossRefPubMed
10.
Zurück zum Zitat Schwab JO, Bonnemeier H, Kleemann T et al (2015) Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol Off J Ger Card Soc 104:1021–1032. doi:10.1007/s00392-015-0870-z CrossRef Schwab JO, Bonnemeier H, Kleemann T et al (2015) Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol Off J Ger Card Soc 104:1021–1032. doi:10.​1007/​s00392-015-0870-z CrossRef
11.
Zurück zum Zitat Theuns DAMJ, Rivero-Ayerza M, Goedhart DM et al (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:1060–1066. doi:10.1093/europace/eun194 CrossRefPubMed Theuns DAMJ, Rivero-Ayerza M, Goedhart DM et al (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:1060–1066. doi:10.​1093/​europace/​eun194 CrossRefPubMed
12.
Zurück zum Zitat Tracy CM, Epstein AE, Darbar D et al (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 60:1297–1313. doi:10.1016/j.jacc.2012.07.009 CrossRefPubMed Tracy CM, Epstein AE, Darbar D et al (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 60:1297–1313. doi:10.​1016/​j.​jacc.​2012.​07.​009 CrossRefPubMed
Metadaten
Titel
Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical
verfasst von
Dipl.-Ing. Jan Zdarek
Carsten W. Israel
Publikationsdatum
07.09.2016
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 3/2016
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-016-0455-1

Weitere Artikel der Ausgabe 3/2016

Herzschrittmachertherapie + Elektrophysiologie 3/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.